Dolby Laboratories, Inc.

For the period ended Sep 26, 2025. Filed Nov 18, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Nov 18, 2025

DLB$64.79-0.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except share and per share amounts)

	September 26,2025	September 27,2024
ASSETS
Current assets:
Cash and cash equivalents	$701,893	$482,047
Restricted cash	91,468	95,705
Short-term investments	703	—
Accounts receivable, net of allowance for credit losses of $7,221 and $5,361	331,096	315,465
Contract assets, net of allowance for credit losses of $101 and $106	180,804	197,478
Inventories, net	30,424	33,728
Prepaid expenses and other current assets	51,873	69,994
Total current assets	1,388,261	1,194,417
Long-term investments	80,205	89,267
Property, plant, and equipment, net	470,608	479,109
Operating lease right-of-use assets	33,204	39,046
Intangible assets, net	397,057	434,514
Goodwill	529,900	533,208
Deferred taxes	214,361	219,758
Other non-current assets	114,164	120,609
Total assets	$3,227,760	$3,109,928
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$17,840	$17,380
Accrued liabilities	369,256	347,529
Income taxes payable	8,928	9,045
Contract liabilities	31,382	31,644
Operating lease liabilities	10,384	12,238
Total current liabilities	437,790	417,836
Non-current contract liabilities	29,687	34,593
Non-current operating lease liabilities	28,494	34,754
Other non-current liabilities	99,843	135,852
Total liabilities	595,814	623,035
Commitments and Contingencies (See Note 14)
Stockholders’ equity:
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 60,802,616 shares issued and outstanding as of September 26, 2025 and 59,722,442 as of September 27, 2024	54	53
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 34,660,045 shares issued and outstanding as of September 26, 2025 and 35,670,779 as of September 27, 2024	40	41
Retained earnings	2,634,980	2,496,255
Accumulated other comprehensive loss	(12,517)	(19,187)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,622,557	2,477,162
Noncontrolling interest	9,389	9,731
Total stockholders’ equity	2,631,946	2,486,893
Total liabilities and stockholders’ equity	$3,227,760	$3,109,928

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.